Search Results 161-170 of 2336 for Mão Morta de Volkmann

  1. Study to Evaluate Safety and Preliminary Efficacy of MOR208 With Idelalisib or Venetoclax in R/R CLL/SLL Patients Pretreated With BTKi (COSMOS) - Mayo Clinic

    About this study. This is a two-cohort, multicenter, open-label study of MOR00208 combined with idelalisib or venetoclax in adult patients with R/R CLL or ...

  2. Atezolizumab Immunotherapy in Patients With Advanced NSCLC (AJCC 7th Edition) - Mayo Clinic

    About this study. Phase II trial of induction immunotherapy with atezolizumab for patients with unresectable stage IIIA and IIIB NSCLC (AJCC 7th Edition) ...

  3. Wojciech Pawlina, M.D. - Doctors and Medical Staff - Mayo Clinic

    Post Doctoral Associate - Research related to Relaxin, a hormone of the corpus luteum.Department of Anatomy and Cell Biology, College of Medicine, ...

  4. A Study to Establish Post-Op Opioid Requirements after Hand Soft Tissue Procedures - Mayo Clinic

    The purpose of this study is to access the effectiveness of over-the-counter analgesics in the management of post-operative pain after hand soft tissue surgical ...

  5. Intra-patient Dose Escalation Study Evaluating Efficacy, Safety and Pharmacokinetics of Pasireotide (SOM230) Subcutaneous (s.c.) Followed by Pasireotide LAR in Patients with Dumping Syndrome - Mayo Clinic

    Intra-patient Dose Escalation Study Evaluating Efficacy, Safety and Pharmacokinetics of Pasireotide (SOM230) Subcutaneous (s.c.) Followed by Pasireotide LAR in ...

  6. Biobank Protocol, Rare Diseases Clinical Research Network

    This study is being done to obtain samples from patients with primary hyperoxaluria, cystinuria, adenine phosphoribosyl transferase (APRT) deficiency, and Dent ...

  7. Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors - Mayo Clinic

    Cabozantinib-s-malate may stop the growth of tumor cells by blocking some of the enzymes needed for tumor growth and tumor blood vessel growth. Participation ...

  8. Serum Bovine Immunoglobulin Protein Isolate in Improving Quality of Life and Post-Operative Recovery in Patients With Gynecological Cancer After Undergoing Surgery - Mayo Clinic

    Serum bovine immunoglobulin supplementation may improve the quality of life of patients with gynecological cancer. Participation eligibility. Participant ...

  9. Momelotinib Versus Ruxolitinib in Subjects With Myelofibrosis - Mayo Clinic

    This study is to determine the efficacy of momelotinib (MMB) versus ruxolitinib in participants with primary myelofibrosis (PMF) or post-polycythemia vera or ...

  10. Study Evaluating Efficacy and Safety of Octagam 10% in Patients With Dermatomyositis (Idiopathic Inflammatory Myopathy) - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...